FDA Expands Vemlidy Use to Adolescents With Chronic HBV ...Middle East

Medscape - News
The indication for the nucleoside analog reverse transcriptase inhibitor in children aged 12 years and older is based on safety and efficacy data from a placebo-controlled clinical trial. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Vemlidy Use to Adolescents With Chronic HBV )

Apple Storegoogle play

Also on site :

Most viewed in News